| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K30748066 | CTRPv2 | pan-cancer | AAC | 0.3 | 0.06 |
| mRNA | MG-132 | GDSC1000 | pan-cancer | AAC | -0.16 | 0.07 |
| mRNA | L-685458 | CCLE | pan-cancer | AAC | 0.12 | 0.07 |
| mRNA | navitoclax:pluripotin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.095 | 0.07 |
| mRNA | Nutlin-3 | CCLE | pan-cancer | AAC | 0.12 | 0.07 |
| mRNA | ISOX | CTRPv2 | pan-cancer | AAC | 0.084 | 0.07 |
| mRNA | pac-1 | GDSC1000 | pan-cancer | AAC | 0.11 | 0.07 |
| mRNA | lenvatinib | CTRPv2 | pan-cancer | AAC | 0.097 | 0.07 |
| mRNA | triazolothiadiazine | CTRPv2 | pan-cancer | AAC | 0.079 | 0.07 |
| mRNA | BRD-K33514849 | CTRPv2 | pan-cancer | AAC | -0.35 | 0.07 |